Polaroid Therapeutics conquers milestones in antimicrobial tech for wounds.

1 min read

Polaroid Therapeutics, a Swiss-based biotech start-up, has achieved significant pre-clinical milestones in the development of its antimicrobial polymer technology for the treatment of acute and chronic wounds. The company’s polymer technology disrupts bacterial cells without triggering antimicrobial resistance, a top global public health threat. Polaroid Therapeutics aims to collaborate with industry leaders in advanced wound care to develop superior healthcare products and improve patient outcomes.

Previous Story

Digital magic brings manuscripts close, but also danger and sacrifice.

Next Story

Tech trends: Wearable market booms with big brands leading the way.

Latest from News